Alain Dervaux
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
Papers in
-
- Schizophrenia research and treatment 19
- Bipolar Disorder and Treatment 13
- Pharmacology 20
- Cannabis and Cannabinoid Research 17
- Co-authors
- Xavier Laqueille (44 shared papers)Marie‐Odile Krebs (22 shared papers)Jean‐Pierre Olié (5 shared papers)Marie‐Chantal Bourdel (6 shared papers)Henri Lôo (4 shared papers)Franck Jean Baylé (6 shared papers)Marie‐France Poirier (1 shared paper)Céline Goldberger (4 shared papers)
- Journals
- European Psychiatry (8 papers)European Neuropsychopharmacology (5 papers)American Journal of Psychiatry (5 papers)Schizophrenia Research (5 papers)The Lancet (4 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Alain Dervaux
85 papers receiving 779 citations
Peers
Comparison fields: 5 of 77
- Psychiatry and Mental health 317
- Pharmacology 182
- Clinical Psychology 197
- Toxicology 27
- Biological Psychiatry 16
Countries citing papers authored by Alain Dervaux
This map shows the geographic impact of Alain Dervaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Dervaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Dervaux more than expected).
Fields of papers citing papers by Alain Dervaux
This network shows the impact of papers produced by Alain Dervaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Dervaux. The network helps show where Alain Dervaux may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Dervaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 133 | |
| 2 | 2001 | 123 | |
| 3 | [Cannabis and schizophrenia: demographic and clinical correlates]. | 2003 | 51 |
| 4 | 2010 | 48 | |
| 5 | 2008 | 47 | |
| 6 | 2019 | 32 | |
| 7 | 2004 | 26 | |
| 8 | 2008 | 25 | |
| 9 | 2010 | 22 | |
| 10 | 2010 | 22 | |
| 11 | 2010 | 22 | |
| 12 | 2005 | 20 | |
| 13 | 2016 | 20 | |
| 14 | 2012 | 17 | |
| 15 | 2007 | 16 | |
| 16 | 2005 | 15 | |
| 17 | [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case]. | 2001 | 12 |
| 18 | 2005 | 11 | |
| 19 | 2007 | 10 | |
| 20 | 2002 | 9 |
About Alain Dervaux
Alain Dervaux is a scholar working on Psychiatry and Mental health, Pharmacology, Clinical Psychology, Epidemiology and Neurology, having authored 97 papers that have together received 859 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (19 papers), Cannabis and Cannabinoid Research (17 papers), Substance Abuse Treatment and Outcomes (17 papers), Bipolar Disorder and Treatment (13 papers), Alcoholism and Thiamine Deficiency (8 papers), Smoking Behavior and Cessation (6 papers), Alcohol Consumption and Health Effects (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). The work is most often cited by research in Psychiatry and Mental health (317 citations), Pharmacology (182 citations), Clinical Psychology (197 citations), Toxicology (27 citations) and Biological Psychiatry (16 citations). Alain Dervaux has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Xavier Laqueille, Marie‐Odile Krebs, Jean‐Pierre Olié, Marie‐Chantal Bourdel, Henri Lôo, Franck Jean Baylé, Marie‐France Poirier, Céline Goldberger, David Gourion and Peter Hjelmström. Their work appears in journals such as European Psychiatry, European Neuropsychopharmacology, American Journal of Psychiatry, Schizophrenia Research and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.